[Fibrodysplasia ossificans progressiva and osteoimmunology]
- PMID: 27117614
[Fibrodysplasia ossificans progressiva and osteoimmunology]
Abstract
Fibrodysplasia ossificans progressive (FOP) is a genetic disorder characterized by progressive heterotopic ossification (HO) in skeletal muscle, tendons and ligaments. FOP is caused by gain-of-function mutations of ALK2, a receptor of bone morphogenetic proteins. Immune responses have been suggested to be involved in HO in FOP, because muscle trauma induces acute HO in patients with FOP. Recently, Activin A, a non-osteogenic ligand, was identified as a ligand of the mutated ALK2 to induce HO. It was suggested that Activin A is a novel interface between FOP and osteoimmunology.
Similar articles
-
The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator.Biosci Rep. 2019 Aug 2;39(8):BSR20190377. doi: 10.1042/BSR20190377. Print 2019 Aug 30. Biosci Rep. 2019. PMID: 31341010 Free PMC article. Review.
-
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.Bone. 2018 Apr;109:210-217. doi: 10.1016/j.bone.2017.06.011. Epub 2017 Jun 16. Bone. 2018. PMID: 28629737 Free PMC article. Review.
-
Recent progress in drug development for fibrodysplasia ossificans progressiva.Mol Cell Biochem. 2022 Oct;477(10):2327-2334. doi: 10.1007/s11010-022-04446-9. Epub 2022 May 10. Mol Cell Biochem. 2022. PMID: 35536530 Free PMC article. Review.
-
Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.Bone. 2018 Apr;109:187-191. doi: 10.1016/j.bone.2017.10.028. Epub 2017 Oct 31. Bone. 2018. PMID: 29100956 Review.
-
Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.J Bone Miner Res. 2022 Nov;37(11):2077-2093. doi: 10.1002/jbmr.4617. Epub 2022 Jul 3. J Bone Miner Res. 2022. PMID: 35637634 Free PMC article.